CSL is a leading global biotech company that develops and delivers innovative biotherapies to help people living with life-threatening medical conditions live full lives. CSL’s Research Acceleration Initiative aims to fast-track discovery of innovative biotherapies through partnerships between CSL and global research organizations. Successful applicants will receive funding of up to $400,000 USD over 2 years.

Option 1: Wednesday 17th January 2024 – 4pm ET.

Option 2: Monday 5^th February 2024 – 12pm ET.

These information sessions are targeted towards prospective applicants (i.e. scientists and clinicians). There are two sessions available and both will have the same content – applicants need only attend one session.

Learn more and apply by February 27th.